Subscribe to Newsletter

Retina

Business & Profession Retina

CATT: Five Years On

| Mark Hillen

The five-year follow-up data are in. Half of all patients retain BCVA of 20/40 or better, irrespective of drug used

Subspecialties Basic & Translational Research

On the KUSp of Neuroprotective Medicine

Novel compounds prevent disease progression in mouse models of glaucoma

Subspecialties Basic & Translational Research

Enter the Inflammasome

In the quest to unearth alternative treatment strategies that don't rely on VEGF inhibition, researchers made some surprising discoveries...

Business & Profession Retina

Retinal Imaging: From von Helmholtz to the Future

A journey from pencil drawings of retinal pathology to fluorescence lifetime imaging ophthalmoscopy. By Frank Holz

Subspecialties Retina

Photoreceptor Death, Thanks to a Low-Fat Diet

| Mark Hillen

Retinal angiomatous proliferation (RAP) is driven by oxygen deprivation, right? The road to retinal VEGF expression might be driven, in part, by energy deficiency

Subspecialties Retina

10,000th SPECTRALIS hits the market

Heidelberg Engineering has reached an important corporate milestone with the 10,000th SPECTRALIS® diagnostic imaging platform, which has been delivered to a French retina specialist.

Subspecialties Basic & Translational Research

The Polymath Molecule

From cornea to retina, NGF’s regenerative and neuroprotective potential seems immense. What does the future hold for this versatile little neurotrophin?

Subspecialties Professional Development

Following Destiny’s Path

Sitting Down With... Anat Loewenstein, Chair of the Department of Ophthalmology, Tel Aviv Medical Centre, Professor of Ophthalmology and Vice Dean, Tel Aviv University, Israel.

Business & Profession Health Economics and Policy

The App That Cuts Clinic Queues

Could patient self-testing help to free up eye clinics, and spot macular degeneration earlier than traditional testing methods?

Subspecialties Basic & Translational Research

Protocol T: Two Years On

| Mark Hillen

Benefits achieved in the first year maintained; VA performance gap in patients with low baseline vision narrows

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer element

This new disclaimer element is now part of all brands. It is editable on the start page and will be shown on all pages

Once confirmed we store a cookie to not show the disclaimer again.